Evive Biotech is a global biologics company devoted to developing a portfolio of novel biological therapies for patients worldwide. Evive leverages proprietary technology platforms to advance a series of innovative drug candidates for oncology, inflammatory and metabolic diseases.
Founded in 2004, Evive has already established operations in the US, Singapore and China. As the first biopharmaceutical company to build a platform bringing innovative therapies from China to the world, Evive adopts a holistic approach to drug development, combining exceptional research and commercialization capabilities with world-class in-house regulatory expertise and extensive international management experience.
Through partnerships with industry, physicians, and regulatory authorities, Evive strives to bring revolutionary remedies to the global market quickly and efficiently to address unmet medical needs, making a real and lasting difference to patients and their families worldwide.